DCPS modulates TDP-43-linked neurodegeneration through P-body-mediated RNA decay
Neuron · 2026-06 · 114 (11) · 1970-1985.e12
DOI: 10.1016/j.neuron.2026.01.018 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuron, 2026-06. Verfasst von Yingzhi Ye und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Pharmacology & Therapeutics, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA; Brain Science Institute…. Hauptthemen laut MEDLINE: DNA-Binding Proteins, RNA Stability, Processing Bodies, Neurodegenerative Diseases. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 105 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIA NIH HHS, NHGRI NIH HHS, NINDS NIH HHS.
Abstract (Originalsprache)
The proteinopathy of the RNA-binding protein TDP-43, characterized by nuclear clearance and cytoplasmic inclusion, is a hallmark of multiple neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), and Alzheimer's disease (AD). Through CRISPR interference (CRISPRi) screening in human neurons, we identified the decapping scavenger enzyme (DCPS) as a novel genetic modifier of TDP-43 loss-of-function (LOF)-mediated neurotoxicity. Our findings reveal that TDP-43 LOF leads to aberrant mRNA degradation via dysregulating the properties and activity of processing bodies (P-bodies). TDP-43 interacts with P-body component proteins, potentially influencing their dynamic equilibrium and assembly into ribonucleoprotein (RNP) granules. Loss of TDP-43 hyperactivates P-bodies, increasing mRNA association and RNA decay. Reducing DCPS restores P-body integrity and RNA turnover, ultimately improving neuronal survival. Overall, this study highlights a novel role of TDP-43 in RNA processing through P-body regulation and identifies DCPS as a potential therapeutic target for TDP-43 proteinopathy-related neurodegenerative diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology, Pharmacology & Therapeutics, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA; Brain Science Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21205, US…
- Department of Chemistry and Institute for Biophysical Dynamics, University of Chicago, Chicago, IL 60637, USA; Howard Hughes Medical Institute, Chicago, IL 60637, USA.
- Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
- Department of Chemistry and Institute for Biophysical Dynamics, University of Chicago, Chicago, IL 60637, USA; Howard Hughes Medical Institute, Chicago, IL 60637, USA; Department of Biochemistry and Molecular Biology, U…
Förderung
- NIA NIH HHS
- NHGRI NIH HHS
- NINDS NIH HHS
- Johns Hopkins University Robert Packard Center for ALS Research
- National Institute of Neurological Disorders and Stroke
- National Institute on Aging
Zitieren
APA
Ye, Y., Zhang, Z., Xiao, Y., Zhu, C., Wright, N., Asbury, J., Huang, Y., Wang, W., Gomez-Isaza, L., Troncoso, J. C., He, C., & Sun, S. (2026). DCPS modulates TDP-43-linked neurodegeneration through P-body-mediated RNA decay. Neuron, 114(11), 1970-1985.e12. https://doi.org/10.1016/j.neuron.2026.01.018
Vancouver
Ye Y, Zhang Z, Xiao Y, Zhu C, Wright N, Asbury J, et al. DCPS modulates TDP-43-linked neurodegeneration through P-body-mediated RNA decay. Neuron. 2026;114(11):1970-1985.e12. doi:10.1016/j.neuron.2026.01.018
BibTeX
@article{Ye2026,
author = {Ye, Yingzhi and Zhang, Zhe and Xiao, Yu and Zhu, Chengzhang and Wright, Noelle and Asbury, Julie and Huang, Yongxin and Wang, Weiren and Gomez-Isaza, Laura and Troncoso, Juan C and He, Chuan and Sun, Shuying},
title = {DCPS modulates TDP-43-linked neurodegeneration through P-body-mediated RNA decay},
journal = {Neuron},
year = {2026},
volume = {114},
number = {11},
pages = {1970--1985.e12},
doi = {10.1016/j.neuron.2026.01.018}
}
EUVIMED